Literature DB >> 33592292

Systematic review and meta-analysis of endovascular interventions for Stanford type A aortic dissection.

Simon De Freitas1, Matthew J Rossi2, Steven D Abramowitz2, Javairiah Fatima2, Misaki M Kiguchi2, Raghuveer Vallabhaneni3, Stewart R Walsh4, Edward Y Woo2.   

Abstract

OBJECTIVE: The standard surgical approach to Stanford type A aortic dissection is open repair. However, up to one in four patients will be declined surgery because of prohibitive risk. Patients who are treated nonoperatively have an unacceptably high mortality. Endovascular repair of the ascending aorta is emerging as an alternative treatment for a select group of patients. The reported rates of technical success, mortality, stroke, and reintervention have varied. The objective of the study was to systematically report outcomes for acute type A dissections repaired using an endovascular approach.
METHODS: The systematic review and meta-analysis was conducted in accordance with the PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines. We performed online literature database searches through April 2020. The demographic and procedural characteristics of the individual studies were tabulated. Data on technical success, short-term mortality, stroke, and reintervention were extracted and underwent meta-analysis using a random effects model.
RESULTS: Fourteen studies with 80 cases of aortic dissection (55 acute and 25 subacute) were included in the final analysis. A wide variation was found in technique and device design across the studies. The outcomes rates were estimated at 17% (95% confidence interval [CI], 10%-26%) for mortality, 15% (95% CI, 8%-23%) for technical failure, 11% (95% CI, 6%-19%) for stroke and 18% (95% CI, 9%-31%) for reintervention. The mean Downs and Black quality assessment score was 13.9 ± 3.2.
CONCLUSIONS: The technique for endovascular repair of type A aortic dissection is feasible and reproducible. The results of our meta-analysis demonstrate an acceptable safety profile for inoperable patients who otherwise would have an extremely poor prognosis. Data from clinical trials are required before the technique can be introduced into routine clinical practice.
Copyright © 2021 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aortic dissection; Endovascular; Stanford type A

Mesh:

Year:  2021        PMID: 33592292     DOI: 10.1016/j.jvs.2021.01.054

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  5 in total

1.  Identification of Immune-Related Gene Signature in Stanford Type A Aortic Dissection.

Authors:  Zhaoshui Li; Jumiao Wang; Qiao Yu; Ruxin Shen; Kun Qin; Yu Zhang; Youjin Qiao; Yifan Chi
Journal:  Front Genet       Date:  2022-06-16       Impact factor: 4.772

2.  Anatomical Feasibility Study on Novel Ascending Aortic Endograft With More Proximal Landing Zone for Treatment of Type A Aortic Dissection.

Authors:  Xiaoye Li; Longtu Zhu; Lei Zhang; Chao Song; Hao Zhang; Shibo Xia; Wenying Guo; Zaiping Jing; Qingsheng Lu
Journal:  Front Cardiovasc Med       Date:  2022-04-06

3.  The association between lymphocyte-monocyte ratio and postoperative acute kidney injury in patients with acute type A aortic dissection.

Authors:  Xinwei Mu; Cui Zhang; Wenxiu Chen; Xiaochun Song; Liang Hong; Huan Xu; Yan Qian; Wenhao Zhang; Jiakui Sun; Xiao Shen; Ying Liu; Xiang Wang; Qiankun Shi; Han Liu
Journal:  J Cardiothorac Surg       Date:  2022-04-01       Impact factor: 1.637

4.  Bentall procedure for retrograde type A dissection after endovascular repair in type A aortic dissection: A case report.

Authors:  Li Ma; Long Liu; Sheng Yan; Jun Yan
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

5.  Protocol for Guo's aortIc Arch recoNstrucTion: a prospective, multicentre and single-arm study to evaluate the safety and efficacy of the WeFlow-Arch modular inner branch stent-graft system for aortic arch lesions (GIANT study).

Authors:  Feng Liu; Hongpeng Zhang; Dan Rong; Yangyang Ge; Xin Jia; Jiang Xiong; Xiaohui Ma; Lijun Wang; Tingting Fan; Wei Guo
Journal:  BMJ Open       Date:  2022-10-10       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.